Human Papillomavirus Epidemiology and Prevention: Is There Still a Gender Gap?

cervical cancer epidemiology gender gap human papillomavirus prevention strategies screening vaccination

Journal

Vaccines
ISSN: 2076-393X
Titre abrégé: Vaccines (Basel)
Pays: Switzerland
ID NLM: 101629355

Informations de publication

Date de publication:
04 Jun 2023
Historique:
received: 17 04 2023
revised: 22 05 2023
accepted: 01 06 2023
medline: 28 6 2023
pubmed: 28 6 2023
entrez: 28 6 2023
Statut: epublish

Résumé

Human papillomavirus (HPV) is sexually transmitted, one of the three most common sexually transmitted infections (STIs) in both males and females, and the most common viral STI. A crucial public health strategy to protect people against HPV is vaccination, which has shown its effectiveness in preventing HPV-related diseases. Presently, three types of vaccines are available (bivalent, quadrivalent, and nonvalent), and they all target the two most oncogenic virus genotypes (HPV 16 and 18). In recent years, the need to implement vaccination programmes that include all genders has been discussed in order to achieve herd immunity against HPV. To date, only a few countries have included young males in their vaccination programmes. Thus, our objective with this review is to provide an overview of the epidemiology of HPV and HPV prevention strategies and report the latest findings from the scientific literature.

Sections du résumé

BACKGROUND AND AIM OBJECTIVE
Human papillomavirus (HPV) is sexually transmitted, one of the three most common sexually transmitted infections (STIs) in both males and females, and the most common viral STI. A crucial public health strategy to protect people against HPV is vaccination, which has shown its effectiveness in preventing HPV-related diseases. Presently, three types of vaccines are available (bivalent, quadrivalent, and nonvalent), and they all target the two most oncogenic virus genotypes (HPV 16 and 18). In recent years, the need to implement vaccination programmes that include all genders has been discussed in order to achieve herd immunity against HPV. To date, only a few countries have included young males in their vaccination programmes. Thus, our objective with this review is to provide an overview of the epidemiology of HPV and HPV prevention strategies and report the latest findings from the scientific literature.

Identifiants

pubmed: 37376449
pii: vaccines11061060
doi: 10.3390/vaccines11061060
pmc: PMC10303003
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Références

Vaccine. 2022 Apr 26;40(19):2656-2666
pubmed: 35367068
Vaccines (Basel). 2021 Nov 30;9(12):
pubmed: 34960159
Lancet Public Health. 2020 Apr;5(4):e223-e234
pubmed: 32057317
Cent Eur J Public Health. 2016 Dec;24(4):321-325
pubmed: 28095289
Int J STD AIDS. 2020 Jun;31(7):606-612
pubmed: 32438856
Cancers (Basel). 2022 Sep 07;14(18):
pubmed: 36139514
Prev Med. 2017 May;98:5-14
pubmed: 28279264
J Natl Cancer Inst. 2020 Oct 1;112(10):1038-1046
pubmed: 32091594
Asian Pac J Cancer Prev. 2021 May 01;22(5):1351-1364
pubmed: 34048162
J Mol Med (Berl). 2022 Jun;100(6):829-845
pubmed: 35478255
Environ Res. 2021 Jan;192:110437
pubmed: 33181134
In Vivo. 2021 Nov-Dec;35(6):3203-3209
pubmed: 34697151
NPJ Vaccines. 2023 Apr 1;8(1):49
pubmed: 37005390
J Eur Acad Dermatol Venereol. 2009 Sep;23(9):1035-8
pubmed: 19470067
Lancet Glob Health. 2019 Jan;7(1):e20-e21
pubmed: 30514615
J Infect Dis. 2021 Sep 30;224(12 Suppl 2):S367-S378
pubmed: 34590141
Mutat Res Rev Mutat Res. 2017 Apr - Jun;772:3-12
pubmed: 28528688
Int J Gynaecol Obstet. 2022 Mar;156(3):425-429
pubmed: 33930178
Acta Obstet Gynecol Scand. 2022 Nov;101(11):1328-1336
pubmed: 36177908
Environ Sci Technol. 2013 Feb 19;47(4):1945-51
pubmed: 23346855
Arch Dermatol. 2002 Oct;138(10):1303-7
pubmed: 12374535
Med J Islam Repub Iran. 2021 May 22;35:65
pubmed: 34277502
Front Public Health. 2023 Feb 21;11:1067299
pubmed: 36895694
Front Mol Biosci. 2021 Dec 10;8:758337
pubmed: 34957212
Vaccine. 2019 Apr 24;37(18):2455-2462
pubmed: 30926298
Viruses. 2021 Jul 09;13(7):
pubmed: 34372532
Zhonghua Nan Ke Xue. 2018 Jun;24(6):516-519
pubmed: 30173456
Eur J Cancer. 2017 Jun;78:105-115
pubmed: 28437708
BMJ. 2015 Jun 30;350:h2372
pubmed: 26126623
Cancer Prev Res (Phila). 2016 Feb;9(2):135-41
pubmed: 26701665
Exp Ther Med. 2020 Jul;20(1):91-96
pubmed: 32518604
Laryngoscope Investig Otolaryngol. 2017 May 28;2(4):184-186
pubmed: 28894838
Vaccines (Basel). 2022 Nov 11;10(11):
pubmed: 36423008
N Engl J Med. 2004 Jun 10;350(24):2461-70
pubmed: 15190138
Infect Genet Evol. 2018 Jul;61:134-144
pubmed: 29518579
MedComm (2020). 2020 Dec 03;1(3):400-409
pubmed: 34766131
Virus Res. 2017 Mar 2;231:119-127
pubmed: 28040475
Lancet. 2011 Jan 15;377(9761):183-4
pubmed: 21216001
J Obstet Gynaecol Res. 2017 Mar;43(3):429-435
pubmed: 28165175
Front Public Health. 2021 Jan 20;8:552028
pubmed: 33553082
Curr Oncol. 2022 May 23;29(5):3780-3792
pubmed: 35621693
Nat Rev Dis Primers. 2020 Nov 26;6(1):92
pubmed: 33243986
Int J Cancer. 2017 Aug 15;141(4):664-670
pubmed: 28369882
Viruses. 2018 Dec 19;10(12):
pubmed: 30572620
Biomedicines. 2023 Jan 25;11(2):
pubmed: 36830875
Int J Infect Dis. 2021 Nov;112:136-143
pubmed: 34517047
J Surg Oncol. 2021 Nov;124(6):920-922
pubmed: 34558067
Exp Ther Med. 2020 Dec;20(6):186
pubmed: 33101476
Ann Ig. 2018 Jul-Aug;30(4 Supple 1):28-32
pubmed: 30062377
PLoS One. 2019 May 1;14(5):e0215945
pubmed: 31042762
Pathobiology. 2021;88(2):187-197
pubmed: 33227782
Fertil Steril. 2015 Oct;104(4):838-844.e8
pubmed: 26211884
Viruses. 2021 Jun 08;13(6):
pubmed: 34201028
Vaccine. 2018 Aug 9;36(33):4979-4992
pubmed: 30037416
Clin Infect Dis. 2012 Apr;54(7):891-8
pubmed: 22291111
Cytojournal. 2022 Mar 29;19:21
pubmed: 35510109
Cancer. 2015 Oct 1;121(19):3455-64
pubmed: 26094818
Trends Immunol. 2022 Oct;43(10):815-825
pubmed: 35995705
Med Clin North Am. 2020 Nov;104(6):1063-1078
pubmed: 33099451
J Gen Virol. 2015 Mar;96(Pt 3):607-613
pubmed: 25398789
JAMA Oncol. 2015 Oct;1(7):907-15
pubmed: 26226294
mBio. 2011 Oct 04;2(5):
pubmed: 21972239
MethodsX. 2022 Jun 25;9:101776
pubmed: 35813158
Hum Vaccin Immunother. 2021 Oct 3;17(10):3603-3612
pubmed: 34156312
Prev Med. 2022 Jan;154:106900
pubmed: 34861338
Sci Rep. 2020 Jun 9;10(1):9320
pubmed: 32518378
Vaccine. 2018 May 31;36(23):3368-3374
pubmed: 29729995
Comput Biol Chem. 2020 Apr;85:107209
pubmed: 32120301
BMJ Glob Health. 2021 May;6(5):
pubmed: 34011537
Virol J. 2009 Jun 21;6:83
pubmed: 19545396
PLoS One. 2014 Apr 08;9(4):e93393
pubmed: 24714693
Biomed Pharmacother. 2018 Oct;106:1537-1556
pubmed: 30119229
Eur Urol Focus. 2019 Jan;5(1):42-45
pubmed: 30262198
Oncotarget. 2017 Feb 28;8(9):15294-15306
pubmed: 28122331
Eur J Cancer. 2020 Jul;134:52-59
pubmed: 32460181
J Am Acad Dermatol. 1989 Jul;21(1):41-9
pubmed: 2545749
Am J Surg Pathol. 2018 Aug;42(8):1001-1009
pubmed: 29697437
Respir Med. 2017 May;126:116-121
pubmed: 28427542
PLoS One. 2012;7(10):e48137
pubmed: 23110191
Nat Rev Clin Oncol. 2022 May;19(5):306-327
pubmed: 35105976
Fertil Steril. 2019 Jun;111(6):1236-1242
pubmed: 30922651
Front Public Health. 2022 Jan 31;10:799984
pubmed: 35174123
Hum Vaccin Immunother. 2016 Jun 2;12(6):1594-8
pubmed: 26930138
Int J Gynaecol Obstet. 2021 Oct;155 Suppl 1:28-44
pubmed: 34669203
MMWR Morb Mortal Wkly Rep. 2019 Aug 16;68(32):698-702
pubmed: 31415491
Gels. 2021 Jan 23;7(1):
pubmed: 33498627
Lancet Glob Health. 2020 Feb;8(2):e180-e190
pubmed: 31862245
Gynecol Oncol. 2011 Apr;121(1):148-51
pubmed: 21208649
Expert Rev Vaccines. 2023 Jan-Dec;22(1):161-179
pubmed: 36576068
Front Immunol. 2022 Jan 27;12:805695
pubmed: 35154080
J Med Virol. 2022 Sep;94(9):4478-4484
pubmed: 35527233
Vaccine. 2017 Sep 12;35(38):5102-5109
pubmed: 28807605
Gynecol Oncol. 2018 Nov;151(2):229-234
pubmed: 30197061
Vaccines (Basel). 2021 Nov 23;9(12):
pubmed: 34960120
Best Pract Res Clin Obstet Gynaecol. 2020 May;65:98-108
pubmed: 32291178
Front Oncol. 2022 Oct 26;12:984449
pubmed: 36387151
Food Environ Virol. 2014 Mar;6(1):1-12
pubmed: 24293168
Vaccines (Basel). 2022 Jun 30;10(7):
pubmed: 35891217
Semin Oncol Nurs. 2022 Jun;38(3):151284
pubmed: 35577640
Int J STD AIDS. 2021 Jan;32(1):4-13
pubmed: 33167803
Vaccines (Basel). 2021 Apr 21;9(5):
pubmed: 33919003
Int J Radiat Oncol Biol Phys. 2007 Jan 1;67(1):130-7
pubmed: 16979842
Expert Rev Anti Infect Ther. 2014 Oct;12(10):1165-70
pubmed: 25199987
Expert Rev Vaccines. 2022 Jun;21(6):735-738
pubmed: 35404177
Best Pract Res Clin Obstet Gynaecol. 2020 May;65:109-124
pubmed: 32284298
Prev Med. 2021 Mar;144:106399
pubmed: 33388322
Vaccines (Basel). 2022 Feb 04;10(2):
pubmed: 35214697
Healthcare (Basel). 2022 Feb 18;10(2):
pubmed: 35207002
Rofo. 2020 Oct;192(10):937-944
pubmed: 32731266
Vaccine. 2020 Feb 5;38(6):1315-1331
pubmed: 31836255
Pediatric Health Med Ther. 2020 Feb 04;11:39-46
pubmed: 32099513
Proc Natl Acad Sci U S A. 2011 Feb 1;108(5):2130-5
pubmed: 21245294
Healthcare (Basel). 2023 Jan 03;11(1):
pubmed: 36611607
Am J Trop Med Hyg. 2021 Oct 25;106(2):378-379
pubmed: 34695802

Auteurs

Giovanna Milano (G)

Department of Life Sciences, University of Siena, 53100 Siena, Italy.

Giovanni Guarducci (G)

Post Graduate School of Public Health, University of Siena, 53100 Siena, Italy.

Nicola Nante (N)

Post Graduate School of Public Health, University of Siena, 53100 Siena, Italy.
Department of Molecular and Developmental Medicine, University of Siena, 53100 Siena, Italy.

Emanuele Montomoli (E)

Department of Molecular and Developmental Medicine, University of Siena, 53100 Siena, Italy.
VisMederi S.r.l., 53100 Siena, Italy.
Interuniversity Research Centre on Influenza and Other Transmissible Infections (CIRI-IT), 16132 Genoa, Italy.

Ilaria Manini (I)

Department of Molecular and Developmental Medicine, University of Siena, 53100 Siena, Italy.
Interuniversity Research Centre on Influenza and Other Transmissible Infections (CIRI-IT), 16132 Genoa, Italy.

Classifications MeSH